12 reports of this reaction
2.5% of all WITCH HAZEL reports
#4 most reported adverse reaction
ERYTHEMA is the #4 most commonly reported adverse reaction for WITCH HAZEL, manufactured by Haleon US Holdings LLC. There are 12 FDA adverse event reports linking WITCH HAZEL to ERYTHEMA. This represents approximately 2.5% of all 488 adverse event reports for this drug.
Patients taking WITCH HAZEL who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ERYTHEMA is a less commonly reported adverse event for WITCH HAZEL, but still significant enough to appear in the safety profile.
In addition to erythema, the following adverse reactions have been reported for WITCH HAZEL:
The following drugs have also been linked to erythema in FDA adverse event reports:
ERYTHEMA has been reported as an adverse event in 12 FDA reports for WITCH HAZEL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ERYTHEMA accounts for approximately 2.5% of all adverse event reports for WITCH HAZEL, making it a notable side effect.
If you experience erythema while taking WITCH HAZEL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.